Islam Md Zohorul, Zimmerman Sam, Lindahl Alexis, Weidanz Jon, Ordovas-Montanes Jose, Kostic Aleksandar, Luber Jacob, Robben Michael
Section on Pathophysiology and Molecular Pharmacology, Joslin Diabetes Center, Boston, Massachusetts, United States of America.
Department of Microbiology, Harvard Medical School, Boston, Massachusetts, United States of America.
PLoS One. 2025 Mar 19;20(3):e0317987. doi: 10.1371/journal.pone.0317987. eCollection 2025.
T cells primarily drive the autoimmune destruction of pancreatic beta cells in Type 1 diabetes (T1D). However, the profound yet uncharacterized diversity of the T cell populations in vivo has hindered obtaining a clear picture of the T cell changes that occur longitudinally during T1D onset. This study aimed to identify T cell clonal expansion and distinct transcriptomic signatures associated with T1D progression in Non-Obese Diabetic (NOD) mice. Here we profiled the transcriptome and T cell receptor (TCR) repertoire of T cells at single-cell resolution from longitudinally collected peripheral blood and pancreatic islets of NOD mice using single-cell RNA sequencing technology. We detected disease dependent development of infiltrating CD8 + T cells with altered cytotoxic and inflammatory effector states. In addition, we discovered a high frequency of transcriptionally distinct double negative (DN) T cells that fluctuate throughout T1D pathogenesis. This study identifies potential disease relevant TCR sequences and potential disease biomarkers that can be further characterized through future research.
Life Sci Alliance. 2022-10
Front Endocrinol (Lausanne). 2024
Genome Biol Evol. 2024-3-2
Rom J Morphol Embryol. 2021
Nat Methods. 2021-8
Cell. 2021-6-24
J Diabetes Investig. 2021-10